NVOS

Novo Integrated Sciences, Inc. (NVOS) | Rumor.io

Novo Integrated Sciences

NVOS

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)0%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)12.6M

Net income (annual)-13.3M

Social

What share of all stock conversation is about NVOS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Nov 8

$NVOS has been identified as a potential scam, with some users referencing its OTC history and lack of product delivery.
The stock has experienced a significant price increase, leading some users to speculate about a reversal pump or a potential scam.
Some users have expressed frustration and anger towards individuals who promoted the stock, with one user claiming to have made a profit from a day trade and warning others to be cautious.

Generated by AI

Sentiment

Of the messages about NVOS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	0% -40	76.06% +1.06	92.62% +32.6
Bearish	—	100% +40	23.94% -1.06	7.38% -32.6

Bullish· Aug 16

NVOS has the potential for significant growth with a buyback program in place, supported by funds evidenced by HSBC.
The stock has shown strong momentum, with rising prices and green candles, indicating a positive trend.
The company's S-1 filing suggests a future price of over $0.70, which could lead to a bounce and further price appreciation.

Bearish· Nov 6

The company has undergone three reverse splits since new management took over, significantly diluting the value of the stock.
The CEO made false promises to investors, and the company engaged in questionable practices, including fake events and funding.
The company's stock price plummeted by 70% on the same day the market rose 15%, suggesting a lack of investor confidence and a potential exit liquidity event.

Generated by AI

Topics

Of the messages about NVOS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	70.15%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	8.96%
Technical Analysis	—	—	—	20.9%

Earnings· Feb 1

NVOS has 1.3 million forward to deliver by the 14th, potentially leading to interesting earnings.
Some investors were bearish on NVOS at the beginning of the week, but the stock has since seen an uptick.
NVOS has seen a small but positive return for some investors, though it's not enough to consider closing positions.

Announcements· May 31

Novo Integrated Sciences, Inc. (NVOS) is projected to receive gross funding proceeds of approximately $78 million under the SBLC instrument on or before June 14, 2024.
The company has carried out a value-added operation worth $18 million by selling assets for $78 million that it bought for $60 million six months ago, securing 3 years of cash cover for its operations.
Novo Integrated Sciences' Board of Directors is conducting a strategic review to determine whether to increase the maximum amount under the stock repurchase program to $5 million, based on excess funds generated from the monetizing program.

Controversies· Jun 15

Robert Emil Mattachione, a 32-year-old man from Lighthouse Point, pleaded guilty to one count of conspiracy in a loan scam case involving Novo Integrated Sciences, Inc. (NVOS).
Mattachione was implicated in a scheme to dupe out-of-state companies into sending computer equipment and parts on credit, which he would then close his phony businesses without paying for, making over $100,000 in the process.
Investigators said Mattachione stole up to $500,000 from the scam, and he faces up to five years in prison at his sentencing on September 26.

Technical Analysis· May 31

The momentum indicator for $NVOS is a $1.15 cross to position preload for a new high of day movement past $1.26.
$NVOS has held up well in the bottom consolidation at $1, and a more aggressive inflow rally to test the supply range on a retest and into a blue skies movement past the current high of $1.26 is possible.
Once $NVOS holds the $1 level, it will likely head to $1.36, where the red dotted daily 200 SMA awaits, and profits may be taken, followed by a retracement and a 2nd attempt at the 200 Daily SMA.

Generated by AI

Community

Of the messages about NVOS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	30.99%	8.05%
Newcomers	—	0%	69.01%	91.95%

Regulars· Sep 21

$NVOS has shown signs of life, with the potential to break and base above the 0.33 level, leading to a possible run towards the 0.38-0.4 zone.
The company's hyper growth and positive net income are expected to continue, with a share buyback and non-dilutive loan term setting up a healthy runway for growth.
$NVOS has the potential to be a winner at current prices, with a buyback from the 0.31 break and a strong fundamental position.

Newcomers· Sep 22

The company, Novo Integrated Sciences, is focused on delivering hypergrowth, with its managers employing a diversification strategy to achieve success.
The growth potential of $NVOS is considered huge, with some investors viewing it as a suitable investment for those looking for long-term gains rather than day traders.
The stock's recent performance is seen as a sign of potential manipulation, with some users suggesting that the price is being artificially lowered despite positive news, including a possible revenue boost in the future.

Generated by AI

Also Discussed

Investors talking about NVOS also mention

#	Name	Attention
1	EBET - EBET, Inc.	——
2	PaxMedica Inc.PXMD	0%0
3	Hub Cyber Security Ltd.HUBC	0%+0
4	PBLA - Panbela Therapeutics, Inc.	——
5	Cosmos Health Inc.COSM	0.02%+0.01
6	Genius Group Ltd.GNS	0.37%-0.12
7	Avalo Therapeutics, Inc.AVTX	0%new
8	ETAO - ETAO International Co., Ltd.	——
9	T2 Biosystems, Inc.TTOO	0%new
10	AXLA - Axcella Health Inc.	——

Novo Integrated Sciences, Inc.

Healthcare
Medical Care Facilities

Novo Integrated Sciences, Inc. is a diversified healthcare provider specializing in multidisciplinary primary care and wellness services, primarily operating through its subsidiaries in Canada and the United States. The company delivers an integrated suite of healthcare solutions, encompassing physiotherapy, chiropractic and manual therapies, occupational therapy, eldercare, massage therapy, acupuncture, neurological rehabilitation, and specialized programs for brain injury, concussion management, and women’s health. These services target a broad spectrum of patients, including pediatric, adult, and geriatric populations, across outpatient clinics as well as long-term care and community settings. In addition to clinical services, Novo Integrated Sciences develops, manufactures, and distributes wellness products such as micro-dosing iodine solutions and dietary supplement pouches. The company incorporates advanced medical technology—including telemedicine platforms, remote patient monitoring, and personalized health diagnostics—to enhance patient outcomes and broaden its market reach. By integrating rehabilitative science with medical innovation, Novo Integrated Sciences positions itself as a unique player addressing evolving needs in the healthcare sector, with its revenue primarily generated from Canadian clinical operations and product sales.

Website

Location

11120 NE 2nd Street

Bellevue, WA, 98004

United States

Social

What share of all stock conversation is about NVOS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Nov 8

$NVOS has been identified as a potential scam, with some users referencing its OTC history and lack of product delivery.
The stock has experienced a significant price increase, leading some users to speculate about a reversal pump or a potential scam.
Some users have expressed frustration and anger towards individuals who promoted the stock, with one user claiming to have made a profit from a day trade and warning others to be cautious.

Generated by AI

Sentiment

Of the messages about NVOS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	0% -40	76.06% +1.06	92.62% +32.6
Bearish	—	100% +40	23.94% -1.06	7.38% -32.6

Bullish· Aug 16

NVOS has the potential for significant growth with a buyback program in place, supported by funds evidenced by HSBC.
The stock has shown strong momentum, with rising prices and green candles, indicating a positive trend.
The company's S-1 filing suggests a future price of over $0.70, which could lead to a bounce and further price appreciation.

Bearish· Nov 6

The company has undergone three reverse splits since new management took over, significantly diluting the value of the stock.
The CEO made false promises to investors, and the company engaged in questionable practices, including fake events and funding.
The company's stock price plummeted by 70% on the same day the market rose 15%, suggesting a lack of investor confidence and a potential exit liquidity event.

Generated by AI

Topics

Of the messages about NVOS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	70.15%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	8.96%
Technical Analysis	—	—	—	20.9%

Earnings· Feb 1

NVOS has 1.3 million forward to deliver by the 14th, potentially leading to interesting earnings.
Some investors were bearish on NVOS at the beginning of the week, but the stock has since seen an uptick.
NVOS has seen a small but positive return for some investors, though it's not enough to consider closing positions.

Announcements· May 31

Novo Integrated Sciences, Inc. (NVOS) is projected to receive gross funding proceeds of approximately $78 million under the SBLC instrument on or before June 14, 2024.
The company has carried out a value-added operation worth $18 million by selling assets for $78 million that it bought for $60 million six months ago, securing 3 years of cash cover for its operations.
Novo Integrated Sciences' Board of Directors is conducting a strategic review to determine whether to increase the maximum amount under the stock repurchase program to $5 million, based on excess funds generated from the monetizing program.

Controversies· Jun 15

Robert Emil Mattachione, a 32-year-old man from Lighthouse Point, pleaded guilty to one count of conspiracy in a loan scam case involving Novo Integrated Sciences, Inc. (NVOS).
Mattachione was implicated in a scheme to dupe out-of-state companies into sending computer equipment and parts on credit, which he would then close his phony businesses without paying for, making over $100,000 in the process.
Investigators said Mattachione stole up to $500,000 from the scam, and he faces up to five years in prison at his sentencing on September 26.

Technical Analysis· May 31

The momentum indicator for $NVOS is a $1.15 cross to position preload for a new high of day movement past $1.26.
$NVOS has held up well in the bottom consolidation at $1, and a more aggressive inflow rally to test the supply range on a retest and into a blue skies movement past the current high of $1.26 is possible.
Once $NVOS holds the $1 level, it will likely head to $1.36, where the red dotted daily 200 SMA awaits, and profits may be taken, followed by a retracement and a 2nd attempt at the 200 Daily SMA.

Generated by AI

Community

Of the messages about NVOS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	30.99%	8.05%
Newcomers	—	0%	69.01%	91.95%

Regulars· Sep 21

$NVOS has shown signs of life, with the potential to break and base above the 0.33 level, leading to a possible run towards the 0.38-0.4 zone.
The company's hyper growth and positive net income are expected to continue, with a share buyback and non-dilutive loan term setting up a healthy runway for growth.
$NVOS has the potential to be a winner at current prices, with a buyback from the 0.31 break and a strong fundamental position.

Newcomers· Sep 22

The company, Novo Integrated Sciences, is focused on delivering hypergrowth, with its managers employing a diversification strategy to achieve success.
The growth potential of $NVOS is considered huge, with some investors viewing it as a suitable investment for those looking for long-term gains rather than day traders.
The stock's recent performance is seen as a sign of potential manipulation, with some users suggesting that the price is being artificially lowered despite positive news, including a possible revenue boost in the future.

Generated by AI

Novo Integrated Sciences

Social

Nov 8

Sentiment

Bullish· Aug 16

Bearish· Nov 6

Topics

Earnings· Feb 1

Announcements· May 31

Controversies· Jun 15

Technical Analysis· May 31

Community

Regulars· Sep 21

Newcomers· Sep 22

Also Discussed

Novo Integrated Sciences, Inc.

Company Information

Location

Also Discussed

Social

Nov 8

Sentiment

Bullish· Aug 16

Bearish· Nov 6

Topics

Earnings· Feb 1

Announcements· May 31

Controversies· Jun 15

Technical Analysis· May 31

Community

Regulars· Sep 21

Newcomers· Sep 22